Keren Paz

3.7k total citations · 1 hit paper
33 papers, 2.6k citations indexed

About

Keren Paz is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Keren Paz has authored 33 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Keren Paz's work include Metabolism, Diabetes, and Cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Keren Paz is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Keren Paz collaborates with scholars based in United States, Israel and Croatia. Keren Paz's co-authors include Yehiel Zick, Derek LeRoith, Hannah Kanety, Rina Hemi, Thomas Söllner, Francesco Parlati, James A. McNew, Avraham Karasik, Fabienne Paumet and Robert J. Johnston and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Keren Paz

33 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Compartmental specificity of cellular membrane fusion encoded in SNARE proteins

2000 537 citations James A. McNew, Francesco Parlati et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keren Paz United States	21	1.7k	701	560	346	329	33	2.6k
Motoi Ohba Japan	38	2.3k 1.3×	421 0.6×	601 1.1×	404 1.2×	361 1.1×	66	3.3k
Heike Döppler United States	31	2.0k 1.2×	453 0.6×	898 1.6×	257 0.7×	518 1.6×	50	3.1k
Tania Maffucci United Kingdom	27	1.8k 1.0×	723 1.0×	321 0.6×	180 0.5×	222 0.7×	52	2.6k
Norman J. Kennedy United States	23	2.2k 1.3×	359 0.5×	553 1.0×	287 0.8×	453 1.4×	32	3.1k
Penny E. Lovat United Kingdom	34	1.7k 1.0×	708 1.0×	479 0.9×	166 0.5×	291 0.9×	88	2.9k
Anutosh Chakraborty United States	23	1.3k 0.8×	529 0.8×	619 1.1×	244 0.7×	187 0.6×	36	2.2k
Christopher Belham United Kingdom	15	2.3k 1.3×	629 0.9×	287 0.5×	359 1.0×	272 0.8×	16	3.0k
Bruno Ségui France	31	1.6k 0.9×	444 0.6×	637 1.1×	360 1.0×	245 0.7×	90	2.8k
Sang-Oh Yoon United States	21	2.0k 1.1×	393 0.6×	584 1.0×	223 0.6×	570 1.7×	30	2.8k
Yonghe Li United States	35	2.4k 1.4×	574 0.8×	807 1.4×	289 0.8×	715 2.2×	57	3.7k

Countries citing papers authored by Keren Paz

Since Specialization

Citations

This map shows the geographic impact of Keren Paz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keren Paz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keren Paz more than expected).

Fields of papers citing papers by Keren Paz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keren Paz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keren Paz. The network helps show where Keren Paz may publish in the future.

Co-authorship network of co-authors of Keren Paz

This figure shows the co-authorship network connecting the top 25 collaborators of Keren Paz. A scholar is included among the top collaborators of Keren Paz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keren Paz. Keren Paz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teng, Pang-ning, Nicholas W. Bateman, Guisong Wang, et al.. (2017). Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Human Cell. 30(3). 226–236. 7 indexed citations

Brait, Mariana, Evgeny Izumchenko, Luciane T. Kagohara, et al.. (2017). Comparative mutational landscape analysis of patient-derived tumour xenografts. British Journal of Cancer. 116(4). 515–523. 10 indexed citations

Zhou, Yan, S. E. Lysenko, Linara Gabitova, et al.. (2016). Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer. Clinical Cancer Research. 22(24). 6153–6163. 47 indexed citations

Šmída, Michal, Ferran Fece de la Cruz, Claudia Kerzendorfer, et al.. (2016). MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated. Nature Communications. 7(1). 13701–13701. 33 indexed citations

Zhu, Qingsong, Evgeny Izumchenko, Alexander Aliper, et al.. (2015). Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients. Human Genome Variation. 2(1). 15009–15009. 40 indexed citations

Moran, Diarmuid, Patricia B. Trusk, Karen Pry, et al.. (2014). KRAS Mutation Status Is Associated with Enhanced Dependency on Folate Metabolism Pathways in Non–Small Cell Lung Cancer Cells. Molecular Cancer Therapeutics. 13(6). 1611–1624. 55 indexed citations

Izumchenko, Evgeny, Xiaofei Chang, Christina Michailidi, et al.. (2014). The TGFβ–miR200–MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors. Cancer Research. 74(14). 3995–4005. 104 indexed citations

Garralda, Elena, Keren Paz, Pedro P. López‐Casas, et al.. (2014). Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment. Clinical Cancer Research. 20(9). 2476–2484. 107 indexed citations

Brennan, Laura, Marie Prewett, Inga Duignan, et al.. (2014). A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth. Cancer Biology & Therapy. 15(9). 1208–1218. 11 indexed citations

10.

Stebbing, Justin, Keren Paz, Gary K. Schwartz, et al.. (2014). Patient‐derived xenografts for individualized care in advanced sarcoma. Cancer. 120(13). 2006–2015. 120 indexed citations

11.

Prewett, Marie, Rajiv Bassi, Keren Paz, et al.. (2011). Estimating preclinical efficacy targets utilizing cetuximab efficacy in KRAS mutant and wild-type colorectal cancer models.. PubMed. 31(6). 2149–60. 2 indexed citations

12.

Paz, Keren & Zhenping Zhu. (2005). Recent advances in targeted therapy of human myelogenous leukaemia. Expert Opinion on Therapeutic Targets. 9(6). 1147–1163. 2 indexed citations

13.

Paz, Keren, Nicholas D. Socci, Erik van Nimwegen, Agnès Viale, & James Darnell. (2004). Transformation fingerprint: induced STAT3-C, v-Src and Ha-Ras cause small initial changes but similar established profiles in mRNA. Oncogene. 23(52). 8455–8463. 22 indexed citations

14.

Boura‐Halfon, Sigalit, et al.. (2003). Extracellular Matrix Proteins Modulate Endocytosis of the Insulin Receptor. Journal of Biological Chemistry. 278(18). 16397–16404. 17 indexed citations

15.

Hemi, Rina, et al.. (2002). Transactivation of ErbB2 and ErbB3 by Tumor Necrosis Factor-α and Anisomycin Leads to Impaired Insulin Signaling through Serine/Threonine Phosphorylation of IRS Proteins. Journal of Biological Chemistry. 277(11). 8961–8969. 42 indexed citations

16.

McNew, James A., Francesco Parlati, Ryouichi Fukuda, et al.. (2000). Compartmental specificity of cellular membrane fusion encoded in SNARE proteins. Nature. 407(6801). 153–159. 537 indexed citations breakdown →

17.

Paz, Keren, Yanfang Liu, Hagai Shorer, et al.. (1999). Phosphorylation of Insulin Receptor Substrate-1 (IRS-1) by Protein Kinase B Positively Regulates IRS-1 Function. Journal of Biological Chemistry. 274(40). 28816–28822. 159 indexed citations

18.

Paz, Keren, Yanfang Liu, Hagai Shorer, et al.. (1999). Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function.. Journal of Biological Chemistry. 274(45). 32528–32528. 13 indexed citations

19.

Paz, Keren, Rina Hemi, Derek LeRoith, et al.. (1997). A Molecular Basis for Insulin Resistance. Journal of Biological Chemistry. 272(47). 29911–29918. 442 indexed citations

20.

Paz, Keren, et al.. (1996). Interaction between the Insulin Receptor and Its Downstream Effectors. Journal of Biological Chemistry. 271(12). 6998–7003. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact